Latest Articles

WuXi Advanced Therapies Ticaros Approval

Clinical Phase I/II IND Approval! The first cell therapy project in Korea supported by WuXi Advanced Therapies receives MFDS approval

All articles

August 12, 2022

WuXi Advanced Therapies Announces Licensing Agreement with Janssen

WuXi Advanced Therapies TESSA AAV Janssen

January 7, 2022

WuXi Advanced Therapies Testing Facility To Receive EMA GMP Certificate for New Philadelphia Facility

WuXi Advanced Therapies R400 Philadelphia

Resources

Gain access to white papers, posters, videos, case studies, brochures and more.

XOFLX^™ stable cell lines: a flexible platform for lentiviral vector production

Poster
Promoter Screening to Enhance Scalable Recombinant AAV Manufacture from TESSA^®

Poster
Infectivity Measurements of AAV Vectors Using TESSA^®-Rep Enabled AAV Titration (TREAT)

Poster

Access All Resources

Ameba Creative Studio